Amarin (AMRN) Stock Forecast & Price Target

→ Historic NVIDIA partnership could send this tiny AI stock soaring... (From Behind the Markets) (Ad)

$0.73

-0.03 (-3.95%)

(As of 06/18/2024 ET)

Amarin - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce
Based on 4 Analyst Ratings

Consensus Price Target

$1.08
48.38% Upside

High Forecast	$1.25
Average Forecast	$1.08
Low Forecast	$1.00

Type	Current Forecast 6/20/23 to 6/19/24	1 Month Ago 5/21/23 to 5/20/24	3 Months Ago 3/22/23 to 3/21/24	1 Year Ago 6/20/22 to 6/20/23
Consensus Rating	Reduce	Reduce	Reduce	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$1.08	$1.08	$1.08	$2.50
Forecasted Upside	48.38% Upside	5.99% Upside	5.99% Upside	105.76% Upside

Get Amarin Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AMRN and its competitors with MarketBeat's FREE daily newsletter.

Ad InvestorPlace

Must-See: Elon’s New Invention is Absolutely Insane

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

AMRN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AMRN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Amarin Stock vs. The Competition

Type	Amarin	Medical Companies	S&P 500
Consensus Rating Score	1.75	2.70	2.50
Consensus Rating	Reduce	Moderate Buy	Hold
Predicted Upside	48.38% Upside	1,068.19% Upside	11.31% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/18/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight
11/20/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Underweight
10/25/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$3.00 ➝ $1.00	+31.53%
7/20/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sell	$1.50 ➝ $1.00	-7.41%
7/19/2023	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$2.00 ➝ $1.25	-12.59%
10/19/2022	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Ruiz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Market Perform	$3.00 ➝ $2.00	+70.94%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:01 AM ET.

AMRN Forecast - Frequently Asked Questions

What is Amarin's stock forecast and purchase recommendation?: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Amarin is $1.08, with a high forecast of $1.25 and a low forecast of $1.00. The consensus rating for Amarin stock is Reduce based on the current 2 sell ratings, 1 hold rating and 1 buy rating for AMRN. Learn more on AMRN's analyst rating history.
Do Wall Street analysts like Amarin more than its competitors?: Analysts like Amarin less than other "medical" companies. The consensus rating for Amarin is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AMRN compares to other companies.
Does Amarin's stock price have much upside?: According to analysts, Amarin's stock has a predicted upside of 5.99% based on their 12-month stock forecasts.